Assessment of pharmaceuticals fate in a model environment

Water, Air, and Soil Pollution

Volumn 218, Issue 1-4, 2011, Pages 413-422

  Domènech, Xavier ^a   Ribera, Marc ^a   Peral, José ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Multiphase model; Pharmaceuticals; Predicted environmental concentration

Indexed keywords

ENVIRONMENTAL CONCENTRATION; ENVIRONMENTAL FATE; ENVIRONMENTAL SYSTEMS; FUGACITY MODEL; GLUCURONIDES; HIGH WATER; MULTIPHASE MODEL; PARENT MOLECULES; PARTIAL DEGRADATION; PREDICTED ENVIRONMENTAL CONCENTRATION; PREDICTED ENVIRONMENTAL CONCENTRATIONS; RATE OF CONSUMPTION; REGIONAL MODEL; RESIDENCE TIME; SUSPENDED MATTERS; WATER PHASE;

ANOXIC SEDIMENTS; DRUG PRODUCTS; SEWAGE; SEWAGE TREATMENT; SEWAGE TREATMENT PLANTS; SUSPENDED SEDIMENTS; VOLATILE ORGANIC COMPOUNDS;

GEOLOGIC MODELS;

AMLODIPINE; ATORVASTATIN; BEZAFIBRATE; CAPTOPRIL; CARBAMAZEPINE; CELECOXIB; CIPROFLOXACIN; CITALOPRAM; CLARITHROMYCIN; CLOPIDOGREL; DIAZEPAM; DICLOFENAC; DILTIAZEM; ERYTHROMYCIN; FLUOXETINE; GABAPENTIN; GLUCURONIDE; IBUPROFEN; IOPROMIDE; KETOPROFEN; METOPROLOL; NAPROXEN; NIMODIPINE; OMEPRAZOLE; OXAZEPAM; PANTOPRAZOLE; PARACETAMOL; VOLATILE ORGANIC COMPOUND; WATER;

CONCENTRATION (COMPOSITION); DRUG; ECOLOGICAL MODELING; ENVIRONMENTAL FATE; EXPERIMENTAL STUDY; FUGACITY; METABOLISM; POLLUTION INCIDENCE; SEWAGE; VOLATILE ORGANIC COMPOUND;

AIR POLLUTION; ANALYTICAL PARAMETERS; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DEGRADATION; DRUG HYDROLYSIS; DRUG METABOLISM; DRUG USE; ENVIRONMENTAL HEALTH; ENVIRONMENTAL MONITORING; MULTIPHASE MODEL; NONBIOLOGICAL MODEL; PHYSICAL CHEMISTRY; POLLUTION TRANSPORT; PREDICTION; RESIDENCE TIME; SEDIMENT; SEWAGE TREATMENT PLANT; SOIL POLLUTION; SPAIN; SUSPENDED PARTICULATE MATTER; WATER POLLUTION;

SPAIN;

EID: 80053561644     PISSN: 00496979     EISSN: 15732932     Source Type: Journal    
DOI: 10.1007/s11270-010-0655-y     Document Type: Article

References (27)

1. ® Windows, v 4.00. Washington: United States Environmental Protection Agency.
2. Benotti, M. J., Trenholm, R., Vanderford, B., Holady, J. C., Stanford, B. D., & Snyder, S. A. (2009). Pharmaceuticals and endocrine disrupting compounds in US drinking water. Environmental Science & Technology, 43, 597-603.
3. Carballa, M., Omil, F., & Lema, J. M. (2008). Comparison of predicted and measured concentrations of selected pharmaceuticals, fragrances and hormones in Spanish sewage. Chemosphere, 72, 1118-1123.
4. Clark, J., Henry, G., & Mackay, D. (1995). Fugacity analysis and model organic chemical fate in a sewage treatment plant. Environmental Science and Technology, 29, 1488-1494.
5. Department of Toxic Substances Control (DTSC). (1993). CalTOX, A multimedia total-exposure model for hazardous-wastes sites part I: executive summary. Prepared for the State of California, Department Toxic Substances Control, Lawrence Livermore National Laboratory, Livermore, CA, UCRL-CR-111456PtI.
6. EMEA. (2006). Guideline on the environmental risk assessment of medicinal products for human use. CMP/SWP4447/00, European Medicines Agency.
7. European Commission. (2003). Technical guidance document in support of commission directive 93/67/EEC on Risk Assessment for new notified substances. Commission Regulation No 1488/94 on Risk Assessment for existing substances and Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market. Accessed from http://ecb.jrc.ec. europa.eu/tgdoc/. Accessed on 27 April 2010.
8. European Commission. (2004). European Union system for the evaluation of substances 2.0 (EUSES 2.0). Prepared for the European Chemicals Bureau by the National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands. Available via the European Chemicals Bureau, http://ecb.jrc.it.
9. González, S., Català, M., Romo, R., Rodríguez, J. L., Gil de Miguel, A., & Valcárcel, Y. (2010). Pollution by psychoactive pharmaceutical in the rivers of Madrid metropolitan area (Spain). Environment International, 36, 195-201.
10. Gros, M., Petrovic, M., & Barceló, D. (2007). Wastewater treatment plants as a pathway for aquatic contamination by pharmaceuticals in the Ebro river basin (Northeast Spain). Environmental Toxicology and Chemistry, 26, 1553-1562. (Pubitemid 47265495)
11. Khetan, S. K., & Collins, T. J. (2007). Human pharmaceuticals in the environment: A challenge to Green Chemistry. Chemical Reviews, 107, 2319-2364. (Pubitemid 47029096)
12. KNAPPE. (2009). European project: Knowledge and need assessment on pharmaceutical products in environmental waters. Available from: http://www.knappe-eu.org/. Accessed on 27 April 2010.
13. Li, H., Helm, P., & Metcalfe, C. (2010). Sampling in the great lakes for pharmaceuticals, personal care products, and endocrine-disrupting substances using the passive polar organic chemical integrative sampler. Environmental Toxicology and Chemistry, 29, 751-762.
14. Mackay, D. (1979). Finding fugacity feasible. Environmental Science & Technology, 13, 1218-1223. (Pubitemid 10222214)
15. Mackay, D. (1991). Multimedia environmental models. The fugacity approach. Chelsea: Lewis Publishers.
16. Maltby, L. (2006). Environmental risk assessment in chemicals in the environment. In R. E. Hester & R. M. Harrison (Eds.), Assessing and managing risk. London: RSC Publishing.
17. Muñoz, I., López-Doval, J., Ricart, M., Villagrasa, M., Brix, R., Geiszinger, A., et al. (2010). Bridging levels of pharmaceuticals in river water with biological community structure in the Llobregat river basin (Northeast Spain). Environmental Toxicology and Chemistry, 28, 2706-2714.
18. Radjenovic, J., Petrovic, M., & Barceló, D. (2009). Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the convencional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. Water Research, 43, 831-841.
19. Salvito, D., Senna, R., & Federle, T. (2002). A framework for prioritizing fragrance materials for aquatic risk assessment. Environmental Toxicology and Chemistry, 21, 1301-1308. (Pubitemid 34553285)
20. Sherrer, R., & Howard, S. (1977). Use of distribution coefficients in quantitative structure-activity relations. Journal of Medicinal Chemistry, 20, 53-58. (Pubitemid 8020532)
21. Spark version 4.5. Sparc performs automatic reasoning in chemistry. Available from http://ibmlc2.chem.uga.edu/sparc/. Accessed on 27 April 2010.
22. Ternes, T. A. (1998). Occurrence of drugs in German sewage treatment plants and rivers. Water Research, 32, 3245-3260. (Pubitemid 28473035)
23. Togola, A., & Budzinski, H. (2008). Multi-residue analysis of pharmaceutical compounds in aqueous samples. Journal of Chromatography A, 1177, 150-158. (Pubitemid 350256744)
24. Toxnet. Databases on toxicology, hazardous chemicals, environmental health, and toxic releases. Accessed from: http://toxnet.nlm.nih.gov/. Accessed 27 April 2010
25. US EPA. (2000). Interim guidance for using ready and inherent bidegradability tests to derive input data for multimedia models and wastewater treatment plants models. Available from: http://www.epa.gov/oppt/exposure/pubs/ halflife.htm. Accessed on 27 April 2010.
26. Vanderford, B., & Snyde, R. S. (2006). Analysis of pharmaceuticals in water by isotope dilution liquid chromatography/tandem mass spectrometry. Environmental Science & Technology, 40, 7312-7320. (Pubitemid 44871842)
27. Yoshida, F., & Topliss, J. (2000). QSAR model for drug human oral bioavailability. Journal of Medicinal Chemistry, 43, 2575-2585. (Pubitemid 30437140)